Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.

Jung, Yoo Jin; Tweedie, David; Scerba, Michael T; Greig, Nigel H

Jung, Yoo Jin; Tweedie, David; Scerba, Michael T; Greig, Nigel H.

Afiliação

Jung YJ; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Tweedie D; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Scerba MT; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Greig NH; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.

Front Cell Dev Biol ; 7: 313, 2019.

Article em En | MEDLINE | ID: mdl-31867326

Palavras-chave

apremilast; immunomodulatory imide drugs (IMiDs); lenalidomide; neurodegeneration; neuroinflammation; pomalidomide; thalidomide; tumor necrosis factor-α (TNF-α)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google